Advanced Enzyme Technologies Limited has submitted a regulatory filing to the BSE Limited and the National Stock Exchange of India Ltd. The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The filing serves as an intimation that the audio recording of the conference call held for analysts and investors is now available. This conference call was conducted to discuss the company's unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27).
The call was held on the date of the letter, Wednesday, August 12, 2026. The audio recording has been made available on the company's official website at the specific URL: www.advancedenzymes.com/investors/analyst-corner.
The filing is a follow-up to a previous communication sent by the company on August 04, 2026, which initially intimated the market about the scheduling of this conference call.
The company has also stated that the transcript of the aforementioned conference call will be submitted to the stock exchanges and uploaded onto the same section of the company's website in due course. All disclosed information is also being uploaded on the company's website.
The letter is signed by Sanjay Basantani, who holds the positions of Company Secretary and Head – Legal at Advanced Enzyme Technologies Limited.